Video interview Summit funded to do 'comprehensive job' on two drug programmes Glyn Edwards, chief executive of Summit (LON:SUMM), tells Proactiveinvestors it is now 'really well funded' in excess of two years on two exciting drug programmes. He also reveals the group has attracted new shareholders from the US, a hotbed for biotech investment and plenty of near term upside as both programmes are expected to start phase 2 trial by this Summer, with the Dmd phase 1 b results in by late spring. Http://tinyurl.com/o5vgff2
US Markets - FYI
Due to a three week difference between the start of Daylight Saving in the US and the start of British Summer Time in the UK, the NYSE, NASDAQ and AMEX markets will open at 13:30 and close at 20:00 GMT until 28th March 2014.
It is not Duchenne M D. Whilst this development is so important to the young guys and is full speed ahead,the really important one is C.difficile.The government wants C.difficile out of our hospitals and is prepared to "speed up" the approval process timeframe.So, keep quiet on the progress and front with DMD.So many posters seem to have forgotten C.difficile progress but I think this is the main focus and for me no news is good news . BUY BUY BUY
Summit new investors
Presumably these new holders of more than 3% are as result of the placing - good to see them on board.
Wow look at all those buys!!
Wow! So many buyers...
Bio-Europe Spring -10 - 12 March 14
Just looking through the list of attendees at the above event which starts today in Turin, Italy and runs until Wednesday. It says Summit Plc are there as a participant. I can't see it on their site under Events. Have I just missed this or did we not know about it? http://www.ebdgroup.com/bes/participants/index.php
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.